Biomarkers: an important tool in the characterization of dementia

Ian McKeith

Ian McKeith, FMedSci, MD, FRSB, FRCPsych from Newcastle University, Newcastle, UK talks to us the importance of biomarkers in the characterization of patients suffering from dementia, and discusses a common misunderstanding about their use for this purpose. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

Share this video  
Similar topics
Related videos
1:01
The spread of pathology in Parkinson's disease
Jeffrey Kordower
2:24
An environmental factor: TBI and dementia research
Daniel Perl
2:48
Establishing structural imaging techniques for amyloid deposits
Robert Tycko
2:02
Tau PET imaging: the current landscape
Elizabeth Mormino
4:56
Two sides to the story: clearance in Alzheimer’s disease
Zhen Zhao
Alzheimer’s Disease, Dementia, Dementia with Lewy Bodies
AAIC 2017
Interview
More from Ian McKeith
Guidelines for the diagnosis of DLB
Making HEADWAY into research for DLB
The content of VJDementia is intended for healthcare professionals